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Abstract
Dakin’s solution (DS) is a time-honoured antiseptic that still remains part of the wound
care armamentarium. In spite of its cytotoxicity, some question its use in the current
era. We report the case of a 52-year-old diabetic woman who was admitted for sepsis
because of a severely infected diabetic foot. Urgent surgical drainage and debridement
left a 9× 9-cm deep, complex, infected wound with both bone and tendon involvement.
Treatment with local negative pressure was unsuccessful. DS was regularly instilled
through a tube left in the wound dressing. A marked improvement was observed
with this strategy as the wound bed was much cleaner and fully granulated after
6 weeks. No adverse effects were noted. This case debunks the myth that topical
antiseptics necessarily impair wound healing. DS can still be considered an option for
difficult-to-treat, complex and heavily infected wounds.
Introduction
Dakin’s solution (DS) received its name as homage to its cre-
ator, Henry Dakin. It was first introduced during the World War
I pre-antibiotic era to meet the need of effective treatments for
infected war wounds. Countless limbs and lives were saved
because of this solution (1). The last few decades have seen
a multitude of medical advancements, which have made a new
array of antiseptic medical solutions available to medical prac-
titioners. Nevertheless, Henry Dakin’s formula is still occasion-
ally used in current practice. However, some question if DS still
has any role to play in the current era.
Case report
A 52-year-old woman presented to the emergency department
complaining of a painful discolouration in the left foot with
a 1-week evolution. Her history was remarkable for essential
arterial hypertension and for type 1 diabetes mellitus, known
for 16 years, with insufficient metabolic control and related
complications: retinopathy, stage III chronic kidney disease and
diabetic foot. The latter had led to the amputation of the right
first toe and second left toe in 2007 and 2012, respectively.
On physical examination, the patient had wet gangrene of
the first toe and an extensive necrotic plaque on the medial
border and plantar surface of the left foot (Figure 1A and
B), with marked perilesional inflammatory signs. Both dorsal
and medial plantar foot compartments were under tension.
Additionally, she had a fever (38⋅1∘C), nausea and vomit-
ing. However, she was haemodynamically stable and had no
respiratory distress.
Analytically, the patient had normocytic normochromic
anaemia (haemoglobin 6⋅6× 10 g/l), raised inflammatory
markers (19⋅3× 109/l leucocytes, of which 92% were neu-
trophils, and a C-reactive protein of 284⋅6mg/l), and acute
kidney injury (creatinine 2⋅28mg/dl and urea 159mg/dl). The
X-ray of the left foot (Figure 1C) showed multiple gas bubbles
on the subcutaneous tissue and periosteal erosions on the first
metatarsal bone, suggesting osteomyelitis.
A diagnosis of diabetic foot with severe infection and sep-
sis was made (perfusion, extent, depth, infection and sensation:
PEDIS classification system, grade IV), and she was hospi-
talised under the care of a specialised diabetic foot team.
Urgent surgical drainage and extensive debridement thus
ensued (Figure 2A), leaving the patient with a 9× 9-cm deep
and complex infected wound with dorsal and plantar aponeuro-
sis involvement, exposition of the first metatarsal bone and
Key Messages
• there is some concern that topical antiseptics might
impair wound healing, and some entities strongly dis-
courage their use
• our experience demonstrates that they can be beneficial
if used correctly and in proper time of infection
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Figure 1 (A) Dorsal view of the left foot
at presentation. (B) Medial view. (C)
Dorsal-plantar and oblique X-rays showing
multiple gas bubbles on the subcutaneous
tissue (white arrows).
Figure 2 (A) Twenty-four hours after surgical drainage and debridement.
(B) One week after surgical and local negative pressure treatment.
both extensor and flexor tendons of the first finger. Samples for
microbiological study were collected, and an empirical treat-
ment with broad-spectrum antibiotics was initiated. Dressings
were done with thin gauzes soaked in octenidine solution. A
Doppler ultrasound excluded peripheral arterial disease.
During hospitalisation, the medical team changed the dress-
ings every other day, and wound cleansing and debridement
were performed with Jetox®-ND DeRoyal® using a mixture
of 100-cc saline solution with 40-cc octenidine. Local negative
pressure (LNP) was trialled during the first week, but this strat-
egymet no success (Figure 2B). Following this attempt, DSwas
used by lightly packing gauzes moist with the solution into the
wound and covering it with a secondary dressing. An irrigation
tube was left wrapped in the dressing so that 50 cc of DS could
be instilled every 8 hours to maintain a humid environment.
With the aforementioned local care, antibiotic therapy,
offloading of the foot and treatment of comorbidities, excellent
and steady improvement was observed during 6 weeks of
hospitalisation (Figure 3A–C). The wound was then much
cleaner and completely covered with granulation tissue. The
patient had no complains related to the application of DS, and
no contact dermatitis or other side effects were observed.
Discussion
Diluted sodium hypochlorite, widely known in the medical
community asDS, is a time-honoured topical antiseptic that was
introduced to the wound care armamentarium almost a century
ago (1).
Nowadays, as McCullough et al. noted (2), advanced wound
care knowledge has shifted the paradigm from ‘prevention of
infection’ to ‘creation of an optimal environment for the repair
process’. For some, this raised concerns that antiseptics might
be too cytotoxic for the healing process to occur. Some entities
have even published guidelines that strongly discourage the
use of antiseptics, particularly DS, for wound care (3). In our
perspective, however, wound management is complex and not
as straightforward as each agent has its own advantages as long
as it is used correctly and tailored to each individual’s situation.
Firstly, severely infected wounds clearly benefit from an
aggressive approach in the beginning stages, the so-called
inflammatory phase (1), when the pathogen burden is so high
that any healing process is next to impossible (4). The goal of
this phase is to rapidly decrease the bioburden and debride the
inviable tissues in order to stop the destructive process and the
spread of infection. As long as it is correctly used (as described
below), DS is very useful because of its good antimicrobial and
debridement properties (5–8). After quickly achieving infec-
tion control, the focus can shift to stimulate granulation.
The case we present debunks the myth that antiseptics could
impair the healing process because of their cytotoxic properties.
The wound bed was totally covered with granulation tissue after
6 weeks in spite of being irrigated with 50 cc of DS every 8
hours (Figure 3C). It should be noted that this periodic flooding
contributed to maintaining a moist environment in the wound,
which is optimal to promote granulation (9). Of course, if the
wound is totally clean, the bath can be stopped as DS, much like
other antiseptics, is not a cicatrising agent.
Ulcers are devoid of an epidermal barrier and physiological
skin defences (immune cells, natural skin antimicrobial pep-
tides), thus compromising the local bacterial equilibrium and
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Figure 3 (A) One week of irrigation with
Dakin’s solution; hydrocolloid dressing pro-
tecting the perilesional skin. (B) Four
weeks of irrigation. (C) Complete granu-
lation of wound bed is observed after 6
weeks of irrigation with Dakin’s solution.
favouring infection, especially in patients whose immune func-
tion is defective, such as diabetics with poor metabolic control.
High-risk wounds with a heavy load of inviable, infected tis-
sues, such as in the case we present, might locally benefit from
the use of antiseptics such as DS. Proper usage of DS in wound
care is, however, mandatory to obtain good results. Its antimi-
crobial and debridement proprieties are short lived (6–8 hours),
so applying it only once a day is almost the same as using a dry
dressing, which is utterly inefficient. In our practice, we leave a
tube (butterfly) in the dressing for cyclical instillation into the
wound. Another option would be to undertake frequent dress-
ing changes (three to four times a day), but this is more time-
and resource-consuming.
The case we present is of a diabetic foot with a polimicro-
bial infection and anaerobic involvement, as suggested by the
bubbles of gas seen on the foot’s X-ray (Figure 1C). Unlike
other antiseptics, DS is efficacious against both aerobic and
anaerobic bacteria (5). It is also known that the prevalence of
multidrug-resistant organisms (MDROs) on diabetic foot ulcer
inpatients is high, as observed in a 2011 study performed at our
unit (10). DS has superior activity against MDROs when com-
pared with other antiseptics (11), which further validates our
treatment strategy.
Perilesional skin irritant contact dermatitis is often a concern
(3). In order to prevent this, we use a hydrocolloid dressing to
protect the wound’s borders (Figure 3A). With this procedure,
no irritation is routinely observed.
Lastly, it should be mentioned that the most cited evidence
against DS (3) is from cell cultures and bench investigation.
Recreating how an infected human wound behaves in the lab-
oratory is not an easy task, and the clinical relevance of those
studies should be cautiously interpreted by experienced wound
care practitioners (8).
Conclusion
Discouraging the use of an agent with such empirical and
observational experience accumulated over the years should not
be performed lightly. In our experience, DS is an effective agent
when used correctly and in proper time of infection. It is also our
experience that it does not impair wound-healing potential. DS
should be considered for difficult-to-treat, complex and heavily
infected wounds.
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